2013
DOI: 10.1093/eurheartj/eht308.p1191
|View full text |Cite
|
Sign up to set email alerts
|

Echocardiographic and biological prospective assessment of cardiotoxicity in patients with breast cancer receiving taxanes, anthracyclines and/or trastuzumab

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles